Table 4.
Demographic and clinical data from the 32 cases.
| Demographics | |
|---|---|
| Gender | |
| Males | 13/32 (59.4) |
| Females | 19/32 (40.6) |
| Gastrointestinal symptoms | |
| Abdominal pain | 28/32 (87.5) |
| Nausea | 14/32 (43.8) |
| Vomiting | 20/32 (62.5) |
| Diarrhea | 5/32 (15.6) |
| Constipation | 2/32 (6.3) |
| Anorexia | 3/32 (9.3) |
| Lack of flatus | 1/32 (3.1) |
| No gastrointestinal symptoms | 2/32 (6.3) |
| Respiratory/General symptoms | |
| Dyspnea | 20/32 (62.5) |
| Cough | 14/32 (43.8) |
| Fever | 19/32 (59.4) |
| Myalgia | 4/32 (12.5) |
| Fatigue | 3/32 (9.3) |
| Headache | 2/32 (6.3) |
| No respiratory or general symptoms | 4/32 (12.5) |
| No respiratory symptoms | 2/32 (6.3) |
| COVID-19 Severity | |
| Mild SARS-CoV-2 illness | 8/32 (25) |
| Moderate SARS-CoV-2 illness | 4/32 (12.5) |
| Severe SARS-CoV-2 illness | 10/32 (31.2) |
| Critical SARS-CoV-2 illness/Need for admission to ICU | 10/32 (31.2) |
| Laboratory findings following development of acute pancreatitis | |
| Amylase levels over three times of ULN | 20/27 (74.1) |
| Amylase levels less than three times of ULN | 7/27 (25.9) |
| Lipase levels over three times of ULN | 21/22 (95.5) |
| Lipase levels less than three times of ULN | 1/22 (0.5) |
| Elevated white blood cell count | 12/26 (46.2) |
| White blood cell count with normal limits | 12/26 (46.2) |
| Decreased WBC count | 2/26 (7.6) |
| Elevated levels of CRP | 18/20 (90) |
| C-reactive protein levels within normal limits | 2/20 (10) |
| Imaging features | |
| Acute interstitial edematous pancreatitis | 21/31 (67.8) |
| Necrotizing pancreatitis | 4/31 (12.9) |
| No abnormal imaging findings | 3/31 (9.7) |
| Abdominal CT was not performed due to pregnancy | 1/31 (3.2) |
| Angio-abdominal CT was conducted in order to exclude ischemic changes | 1/31 (3.2) |
| Large pancreatic pseudocyst causing a partial stomach outlet obstruction on abdominal CT | 1/31 (3.2) |
| Medical history | |
| Arterial hypertension | 11/31 (35.5) |
| Diabetes mellitus | 6/31 (19.4) |
| Obesity | 5/31 (16.1) |
| Cholecystectomy | 3/31 (9.7) |
| Asthma | 2/31 (6.5) |
| Chronic kidney disease | 3/31 (9.7) |
| Osteoporosis | 1/31 (3.2) |
| Hypothyroidism | 2/31 (6.5) |
| Gastroesophageal reflux | 1/31 (3.2) |
| Hypercholesterolemia | 1/31 (3.2) |
| Active cancer of larynx and breast | 1/31 (3.2) |
| Thrombophilia | 1/31 (3.2) |
| Pregnancy | 2/31 (6.5) |
| No medical history | 12/31 (38.5) |
| Outcomes | |
| Recovery | 30/30 (100) |
| Death | 0 |
Data are n (%); ULN: Upper limit of normal.